Organogenesis Holdings Inc (ORGO) insider trading
Every open-market stock purchase and sale by Organogenesis Holdings Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Insiders sold $2.6M over the last 12 months (2 sales).
- Last insider buy: Michael Joseph Driscoll (Director), $26.7K, 7 months ago.
Last 12 months: insiders bought $40.1K (2 buys) and sold $2.6M (2 sales). Last close $1.03 on Oct 22, 2026.
Recent ORGO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Mar 9, 2026 | Michael Joseph Driscoll (Director) | Bought | $26.7K |
| Mar 9, 2026 | Arthur S Leibowitz (Director) | Bought | $13.4K |
| Mar 1, 2026 | Robert Cavorsi (President) | Sold (not open market) | $2.2K |
| Feb 18, 2026 | Gary S. Gillheeney (CEO) | Sold (not open market) | $351K |
| Feb 18, 2026 | Gary S. Gillheeney (CEO) | Sold (not open market) | $347K |
| Feb 18, 2026 | Patrick Bilbo (COO) | Sold (not open market) | $62.9K |
| Feb 18, 2026 | Patrick Bilbo (COO) | Sold (not open market) | $62.3K |
| Feb 18, 2026 | David Francisco (CFO) | Sold (not open market) | $56.4K |
| Feb 18, 2026 | David Francisco (CFO) | Sold (not open market) | $55.8K |
| Feb 18, 2026 | Lori Freedman (Officer) | Sold (not open market) | $55.3K |
| Feb 18, 2026 | Lori Freedman (Officer) | Sold (not open market) | $54.8K |
| Feb 18, 2026 | Brian Grow (C-suite exec) | Sold (not open market) | $45.6K |
| Feb 18, 2026 | Brian Grow (C-suite exec) | Sold (not open market) | $45.2K |
| Feb 18, 2026 | Robert Cavorsi (President) | Sold (not open market) | $21.1K |
| Feb 18, 2026 | Robert Cavorsi (President) | Sold (not open market) | $20.9K |
| Feb 18, 2026 | Antonio S. Montecalvo (President) | Sold (not open market) | $14.5K |
| Feb 18, 2026 | Antonio S. Montecalvo (President) | Sold (not open market) | $14.4K |
| Feb 18, 2026 | Gary S. Gillheeney (CEO) | Bought (not open market) | — |
| Feb 18, 2026 | Gary S. Gillheeney (CEO) | Bought (not open market) | — |
| Feb 18, 2026 | Patrick Bilbo (COO) | Bought (not open market) | — |
| Feb 18, 2026 | Patrick Bilbo (COO) | Bought (not open market) | — |
| Feb 18, 2026 | Patrick Bilbo (COO) | Bought (not open market) | — |
| Feb 18, 2026 | Brian Grow (C-suite exec) | Bought (not open market) | — |
| Feb 18, 2026 | Brian Grow (C-suite exec) | Bought (not open market) | — |
| Feb 18, 2026 | David Francisco (CFO) | Bought (not open market) | — |
Who's trading ORGO
- Arthur S Leibowitz, Director: bought $13.4K (1 buy), last Mar 9, 2026
- Michael Joseph Driscoll, Director: bought $26.7K (1 buy), last Mar 9, 2026
- Robert Cavorsi, President: other filings, last Mar 1, 2026
- David Francisco, CFO: other filings, last Feb 18, 2026
- Lori Freedman, Officer: other filings, last Feb 18, 2026
- Gilberto Quintero, Director: other filings, last Feb 18, 2026
- Patrick Bilbo, COO: other filings, last Feb 18, 2026
- Prathyusha Duraibabu, Director: other filings, last Feb 18, 2026
- Brian Grow, C-suite exec: other filings, last Feb 18, 2026
- Michele Ilene Korfin, Director: other filings, last Feb 18, 2026
- Garrett Lustig, Director: other filings, last Feb 18, 2026
- Antonio S. Montecalvo, President: other filings, last Feb 18, 2026
- Jon L Giacomin, Director: other filings, last Feb 18, 2026
- Gary S. Gillheeney, CEO: other filings, last Feb 18, 2026
- Glenn H Nussdorf, 10% owner: sold $2.6M (4 sales), last Dec 16, 2025
Get free alerts when an insider at Organogenesis Holdings Inc files a new trade →